 |
| Smart Inhalers Market |
The global Smart Inhalers Market is estimated to be valued at US$ 374.0 Mn in 2023 and is expected to exhibit a CAGR of 58.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Smart inhalers incorporate digital monitoring technologies that help patients
better manage their respiratory conditions. These connected inhalers have
sensors that can track medication use and send data to a companion smartphone
app. This allows patients and physicians to monitor symptoms and medication
adherence in real-time.
Market key trends:
One of the major trends in the smart inhalers market is the rising development
of combination inhalers integrated with Bluetooth connectivity. Combination inhalers
containing two or more active drugs are gaining traction as they help treat
comorbid respiratory conditions with a single inhaler. Major players are
focusing on developing such combination inhalers integrated with Bluetooth
technology that can automatically send usage data to a connected smartphone.
This allows monitoring treatment patterns and helps physicians modify therapy
for better management of respiratory diseases.
Segment Analysis
Smart inhalers market is segmented into smart dry powder inhalers, smart
metered dose inhalers and smart nebulizers. Among these, the smart metered dose
inhalers segment dominated the market in 2022 and accounted for the largest
market share. This is attributed to wider usage of metered dose inhalers for
treatment of asthma and COPD. The smart metered dose inhalers aids patients to
monitor medication use and adherence to prescribed treatment plans, thereby
driving the growth of this segment.
Key Takeaways
The global Smart
Inhalers Market Share is expected to witness high growth, exhibiting 58% CAGR over the forecast period, due
to increasing prevalence of chronic respiratory diseases like asthma and COPD.
Regional analysis
North America dominated the smart inhalers market and accounted for largest
market share in 2023 owing to rising awareness regarding smart inhalers and
presence of well-established healthcare infrastructure and key market players
in the region. Asia Pacific is expected to witness fastest growth over the
forecast period led by increasing healthcare spending and rising prevalence of
chronic respiratory diseases.
Key players
Key players operating in the smart inhalers market are Adherium Limited,
AstraZeneca, Boehringer Ingelheim, Cohero Health, GSK, Novartis, and ResMed,
among others. GSK and Novartis have strong presence and hold significant share
of the overall market.
Read More,
https://www.insightprobing.com/smart-inhalers-market-trends-size-and-share-analysis/
0 Comments